Atul Deshpande

Atul Deshpande is the Chief Strategy Officer of Peptilogics. He previously worked at IMMEDIATE Therapeutics as a CEO and Board Member. Prior to that he was the Chief Strategy Officer at Harbour BioMed. Before joining HBM, Atul spent 7 years are Sanofi in various roles and was the Global Operations Head for Dupixent driving a successful launch for the brand globally. Atul Deshpande graduated from UC-Irvine with a doctorate in Neurobiology and Behavior and later attended Cranfield School of Management for his MBA studies.